International audienceContext: Clinical surveys have revealed that incidental detection of renal cell carcinoma is rising because of increased use of imaging procedures.Objective: To examine incidence, mortality, and survival trends of renal cell and renal pelvis cancers by age, sex, race, and tumor stage at diagnosis.Design: Calculation of age-adjusted incidence and mortality rates, along with 5-year relative survival rates, using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program.Setting and Participants: Patients diagnosed as having kidney cancer from 1975 through 1995 in the 9 geographic areas covered by tumor registries in the SEER program, which represent about 10% of the US population...
PURPOSE: Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma is uncle...
International audiencePURPOSE OF REVIEW: To analyze the current literature regarding incidental find...
Kidney and renal pelvis cancer is the eighth most common cancer in the US. In 2022, 79,000 new cases...
International audienceContext: Clinical surveys have revealed that incidental detection of renal cel...
Background: Recent data showed that North America has the highest incidence of renal cell carcinoma ...
Renal cell carcinoma (RCC) accounts for 3% of all adult cancers. The incidence rates for kidney canc...
Context: Renal cell carcinoma (RCC) incidence rates are higher in developed countries, where up to h...
Purpose Kidney cancer is one of the fastest rising cancers worldwide. We aimed to examine the trends...
Nationwide databases have implicated an increased incidence of renal cell carcinoma (RCC). The Penns...
Background and Objective: Since the 1990s, multiple studies have reported on an increased incidence ...
PURPOSE: We sought to identify racial differences among histological subtypes of renal cell carcinom...
The incidence of kidney cancer has been rising over the last two decades, especially in cases where ...
PURPOSE: Patients with end-stage renal disease (ESRD) have an increased risk of developing renal ce...
Purpose: We have analyzed the changing trends in surgical treatment of renal tumors over the last 2 ...
Contains fulltext : 96428.pdf (publisher's version ) (Closed access)CONTEXT: Kidne...
PURPOSE: Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma is uncle...
International audiencePURPOSE OF REVIEW: To analyze the current literature regarding incidental find...
Kidney and renal pelvis cancer is the eighth most common cancer in the US. In 2022, 79,000 new cases...
International audienceContext: Clinical surveys have revealed that incidental detection of renal cel...
Background: Recent data showed that North America has the highest incidence of renal cell carcinoma ...
Renal cell carcinoma (RCC) accounts for 3% of all adult cancers. The incidence rates for kidney canc...
Context: Renal cell carcinoma (RCC) incidence rates are higher in developed countries, where up to h...
Purpose Kidney cancer is one of the fastest rising cancers worldwide. We aimed to examine the trends...
Nationwide databases have implicated an increased incidence of renal cell carcinoma (RCC). The Penns...
Background and Objective: Since the 1990s, multiple studies have reported on an increased incidence ...
PURPOSE: We sought to identify racial differences among histological subtypes of renal cell carcinom...
The incidence of kidney cancer has been rising over the last two decades, especially in cases where ...
PURPOSE: Patients with end-stage renal disease (ESRD) have an increased risk of developing renal ce...
Purpose: We have analyzed the changing trends in surgical treatment of renal tumors over the last 2 ...
Contains fulltext : 96428.pdf (publisher's version ) (Closed access)CONTEXT: Kidne...
PURPOSE: Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma is uncle...
International audiencePURPOSE OF REVIEW: To analyze the current literature regarding incidental find...
Kidney and renal pelvis cancer is the eighth most common cancer in the US. In 2022, 79,000 new cases...